cyclosporine has been researched along with Arteriosclerosis, Coronary in 58 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 29 (50.00) | 18.2507 |
2000's | 18 (31.03) | 29.6817 |
2010's | 8 (13.79) | 24.3611 |
2020's | 3 (5.17) | 2.80 |
Authors | Studies |
---|---|
Furui, S; Matsubara, D; Minami, T; Oka, K; Sato, T; Seki, M; Suzuki, S; Yamagata, T; Yokomizo, A | 1 |
Akande, O; Chen, Q; Cholyway, R; Lesnefsky, EJ; Quader, M; Toldo, S | 1 |
Andreassen, AK; Arora, S; Aukrust, P; Bøtker, HE; Dellgren, G; Eiskjær, H; Gude, E; Gullestad, L; Gustafsson, F; Ioanes, D; Karason, K; Rådegran, G; Solbu, D; Ueland, T | 1 |
McCrindle, BW; Rowley, AH | 1 |
Andersson, B; Andreassen, AK; Arora, S; Dellgren, G; Eiskjær, H; Gude, E; Gullestad, L; Gustafsson, F; Jansson, K; Karason, K; Rådegran, G; Solbu, D | 1 |
Burns, JC | 1 |
Andreassen, AK; Arora, S; Aukrust, P; Berge, RK; Broch, K; Dellgren, G; Gude, E; Gullestad, L; Hov, JR; Karason, K; Mayerhofer, CCK; Svardal, A; Trøseid, M; Ueland, T | 1 |
Eifert, S; Grinninger, C; Groetzner, J; Guethoff, S; Hagl, C; Kaczmarek, I; Meiser, BM; Reichart, B; Ueberfuhr, P | 1 |
Akashima, T; Amano, J; Isobe, M; Ito-Amano, M; Suzuki, J; Terasaki, T; Wada, Y | 1 |
Bandorski, D; Bogossian, H; Eckardt, L; Frommeyer, G; Kafchitsas, K; Lemke, B; Matzaroglou, C; Ninios, I; Seyfarth, M; Zarse, M | 1 |
Edwards, BS; Frantz, RP; Kushwaha, SS; Lennon, RJ; Lerman, A; Prasad, A; Raichlin, E; Rihal, CS | 1 |
Bergan, S; Eiskjaer, H; Fagertun, HE; Iversen, M; Mared, L; Nilsson, F; Nyström, U; Simonsen, S; Sipponen, J; Solbu, D | 1 |
Chen, YS; Chi, NH; Chou, NK; Chu, SH; Huang, SC; Jan, CF; Ko, WJ; Lee, CM; Tsao, CI; Wang, SS; Wu, IH; Yu, HY | 1 |
Miller, LW | 1 |
Mohr, FW; Olbrich, HG; Richter, HR; Richter, MH | 1 |
Burke, E; Burkhoff, D; Edwards, N; Itescu, S; LaManca, J; Mancini, D; Marks, AR; Oz, M; Pinney, S | 1 |
Fischereder, M; Hengstenberg, C; Kammerl, MC; Krämer, BK; Marienhagen, J; Schmidt, C; Zülke, C | 1 |
Chan, MC; Gao, SZ; Hunt, SA; Robbins, RC; Shiba, N; Valantine, HA | 1 |
Laher, I; McManus, BM; Moien-Afshari, F | 1 |
Chan, MC; Hunt, SA; Kwok, BW; Robbins, RC; Shiba, N; Valantine, HA | 1 |
Bilińska, M; Wolszakiewicz, J | 1 |
Czer, LS; Kamlot, A; Luthringer, D; Quartel, A; Soukiasian, HJ; Trento, A; Wang, C; Wang, HM | 1 |
Cooke, DT; Hoyt, EG; Kown, MH; Lijkwan, MA; Martens, JM; Murata, S; Peterson, SH; Robbins, RC | 1 |
Balsam, LB; Cooke, DT; Kofidis, T; Mokhtari, GK; Robbins, RC; Tanaka, M; Zwierzchonievska, M | 1 |
Bernstein, D; Burge, M; Chin, C; Gamberg, P; Kouretas, P; Miller, J; Reitz, B; Robbins, R; Ross, M | 1 |
Libby, P; Schoen, FJ; Sukhova, G; Swanson, SJ; Tanaka, H | 1 |
Gmiński, J; Stajszczyk, M | 1 |
Nagamine, S | 1 |
Bouchard, D; Carrier, M; Cartier, R; Despatis, MA; Leung, TK | 1 |
Esato, K; Fujimura, Y; Gohra, H; Hamano, K; Ito, H; Katoh, T; Shirasawa, B; Suzuki, K; Tsuboi, H | 1 |
Bierhaus, A; Dürfeld, F; Haberbosch, W; Heidinger, K; Hölschermann, H; Lohmeyer, J; Maus, U; Nawroth, PP; Tillmanns, H | 1 |
Foegh, ML; Katz, N; Kodama, T; Lou, H; Ramwell, P; Wang, YN | 1 |
Foegh, ML; Katz, N; Kodama, T; Lou, H; Maurice, P; Wang, YN; Zhao, YJ | 1 |
Koskinen, PK; Lemström, KB | 1 |
Mauro, VF; Southworth, MR | 1 |
Esper, E; Filer, SR; Glagov, S; Karp, RB; Sand, ME; Scanu, AM; Simonsen, KK | 1 |
Augustine, S; Chen, CL; Hruban, RH; Lafond-Walker, A; Lowenstein, CJ; Wu, TC | 1 |
Bouchard, D; Buluran, J; Cartier, R; Despatis, MA | 1 |
Poston, RS; Reitz, BA; Robbins, RC; Teranishi, K | 1 |
Asagami, T; Cooke, JP; Poston, RS; Reitz, BA; Robbins, RC; Teranishi, K; Tsao, PS | 1 |
Hachida, M; Hoshi, H; Koyanagi, H; Lu, H; Zhang, XL | 2 |
Aziz, TM; Campbell, C; Deiraniya, A; Dyer, P; el-Gamel, A; Krysiak, P; Rahman, A; Sheldon, S; Yonan, N | 1 |
Esato, K; Fujimura, Y; Gohra, H; Hamano, K; Ito, H; Katoh, T; Zempo, N | 1 |
Esato, K; Fujimura, Y; Hamano, K; Ito, H; Suzuki, K | 1 |
Hachida, M; Hoshi, H; Koyanagi, H; Lu, H; Zhang, X | 2 |
Annalisa, A; Antonio, G; Massimo, F; Maurizio, PG; Panagiotis, T; Sara, P; Sartori, TM; Ugolino, L | 1 |
Furukawa, Y; Hara, M; Hwang, MW; Iwasaki, A; Matsumori, A; Okada, M; Ono, K; Sasayama, S | 1 |
Furutani, Y; Hachida, M; Hoshi, H; Koyanagi, H; Lu, H; Matsuoka, R; Saito, S; Zhang, X | 1 |
Carrier, M; Pellerin, M; Pelletier, GB; Pelletier, LC; Perrault, LP; Robitaille, D; White, M | 1 |
Klauss, V; König, A; Theisen, K | 1 |
Levi, M; Moons, AH; Peters, RJ | 1 |
Mohr, FW; Olbrich, HG; Richter, H; Richter, M; Schramm, D; Skupin, M; Weinert, M | 1 |
Bartels, A; Breithardt, G; Hohage, H; Plenz, G; Schmidt, A; Sindermann, JR; Skaletz-Rorowski, A | 1 |
Esato, K; Hamano, K; Ueki, K | 1 |
Jamieson, SW | 1 |
6 review(s) available for cyclosporine and Arteriosclerosis, Coronary
Article | Year |
---|---|
Cardiovascular toxicities of immunosuppressive agents.
Topics: Adrenal Cortex Hormones; Animals; Cardiovascular System; Coronary Artery Disease; Cyclosporine; Diabetes Mellitus; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Sirolimus; Tacrolimus | 2002 |
Immunosuppression and transplant vascular disease: benefits and adverse effects.
Topics: Animals; Coronary Artery Disease; Cyclosporine; Heart Transplantation; Humans; Immunosuppressive Agents | 2003 |
[Transplant coronary artery disease--treatment with statins].
Topics: Coronary Artery Disease; Cyclosporine; Cytochrome P-450 Enzyme System; Drug Interactions; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Rhabdomyolysis | 2004 |
[Cyclosporin and atherosclerosis].
Topics: Animals; Coronary Artery Disease; Cyclosporine; Heart Transplantation; Humans; Immunosuppression Therapy | 1994 |
The use of HMG-CoA reductase inhibitors to prevent accelerated graft atherosclerosis in heart transplant patients.
Topics: Coronary Artery Disease; Cyclosporine; Drug Interactions; Graft Rejection; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Randomized Controlled Trials as Topic | 1997 |
Tissue factor and coronary artery disease.
Topics: Acute Disease; Angioplasty, Balloon, Coronary; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antibodies, Monoclonal; Anticoagulants; Arginine; Aspirin; Coronary Artery Disease; Coronary Thrombosis; Cyclosporine; Endothelium, Vascular; Factor VIIa; Heparin, Low-Molecular-Weight; Hirudin Therapy; Humans; Hypolipidemic Agents; Leukocytes, Mononuclear; Muscle, Smooth, Vascular; Recombinant Proteins; Thrombin; Thromboplastin | 2002 |
6 trial(s) available for cyclosporine and Arteriosclerosis, Coronary
Article | Year |
---|---|
Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients.
Topics: Adult; Allografts; Calcineurin Inhibitors; Coronary Angiography; Coronary Artery Disease; Cyclosporine; Drug Administration Schedule; Everolimus; Female; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Inflammation Mediators; Male; Middle Aged; Plaque, Atherosclerotic; Prospective Studies; Scandinavian and Nordic Countries; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2018 |
Everolimus Initiation With Early Calcineurin Inhibitor Withdrawal in De Novo Heart Transplant Recipients: Long-term Follow-up From the Randomized SCHEDULE Study.
Topics: Adult; Calcineurin Inhibitors; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Dose-Response Relationship, Drug; Everolimus; Female; Follow-Up Studies; Glomerular Filtration Rate; Glucocorticoids; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Randomized Controlled Trials as Topic; Ultrasonography, Interventional | 2020 |
Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
Topics: Adult; Chi-Square Distribution; Coronary Artery Disease; Cyclosporine; Drug Monitoring; Drug Therapy, Combination; Female; Germany; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Logistic Models; Male; Middle Aged; Mycophenolic Acid; Prospective Studies; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome; Young Adult | 2013 |
Use of rapamycin slows progression of cardiac transplantation vasculopathy.
Topics: Arterial Occlusive Diseases; Autoantibodies; Cardiac Catheterization; Cohort Studies; Coronary Artery Disease; Cyclosporine; Disease Progression; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Infections; Male; Middle Aged; Neoplasms; Prospective Studies; Renal Insufficiency; Sirolimus; Survival Analysis; Treatment Outcome | 2003 |
Cardiovascular risk factors and estimated risk for CAD in a randomized trial comparing calcineurin inhibitors in renal transplantation.
Topics: Calcineurin Inhibitors; Coronary Artery Disease; Cyclosporine; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Prospective Studies; Risk Factors; Survival Analysis; Tacrolimus | 2003 |
A 10-year experience with intravenous thymoglobuline in induction of immunosuppression following heart transplantation.
Topics: Adult; Analysis of Variance; Antilymphocyte Serum; Azathioprine; Coronary Artery Disease; Cyclosporine; Female; Heart Transplantation; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Injections, Intravenous; Lymphocyte Subsets; Male; Mycophenolic Acid; Prednisone; Retrospective Studies; T-Lymphocytes | 1999 |
46 other study(ies) available for cyclosporine and Arteriosclerosis, Coronary
Article | Year |
---|---|
Continuous cyclosporine a infusion in patients with severe Kawasaki disease.
Topics: C-Reactive Protein; Coronary Artery Disease; Cyclosporine; Humans; Immunoglobulins, Intravenous; Infant; Mucocutaneous Lymph Node Syndrome; Treatment Outcome | 2022 |
Infarct Size With Incremental Global Myocardial Ischemia Times: Cyclosporine A in Donation After Circulatory Death Rat Hearts.
Topics: Animals; Coronary Artery Disease; Cyclosporine; Heart; Heart Transplantation; Myocardial Infarction; Rats; Tissue Donors | 2023 |
Improving coronary artery outcomes for children with Kawasaki disease.
Topics: Child; Coronary Artery Disease; Cyclosporine; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lymph Node Syndrome | 2019 |
Cyclosporine and coronary outcomes in Kawasaki disease.
Topics: Coronary Artery Disease; Coronary Vessels; Cyclosporine; Humans; Immunoglobulins, Intravenous; Mucocutaneous Lymph Node Syndrome | 2019 |
The carnitine-butyrobetaine-TMAO pathway after cardiac transplant: Impact on cardiac allograft vasculopathy and acute rejection.
Topics: Acute Disease; Adult; Aged; Betaine; Carnitine; Coronary Artery Disease; Cyclosporine; Everolimus; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Methylamines; Microbiota; Middle Aged; Postoperative Complications | 2019 |
Characteristics of cardiac allograft vasculopathy induced by immunomodulation in the miniature Swine.
Topics: Animals; Cell Proliferation; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Disease Models, Animal; Genetic Markers; Heart Transplantation; Histocompatibility; Histocompatibility Antigens Class I; Histocompatibility Antigens Class II; Immunosuppressive Agents; In Situ Hybridization, Fluorescence; Male; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Severity of Illness Index; Swine; Swine, Miniature; Time Factors; Transplantation, Heterotopic; Y Chromosome | 2015 |
Expression of NO Synthase Under Medication with Cyclosporine A, Mycophenolate Mofetil, and Tacrolimus during Development of Transplant Vasculopathy on Rat Cardiac Allograft.
Topics: Allografts; Animals; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Disease Models, Animal; Down-Regulation; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Mycophenolic Acid; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats, Inbred Lew; Tacrolimus; Time Factors | 2016 |
Features of cardiac allograft coronary endothelial dysfunction.
Topics: Adult; Coronary Artery Disease; Cyclosporine; Endothelial Cells; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Nitric Oxide; Ultrasonography, Interventional | 2009 |
Cyclosporine C2 levels have impact on incidence of rejection in de novo lung but not heart transplant recipients: the NOCTURNE study.
Topics: Adult; Area Under Curve; Blood Pressure; Cardiomyopathies; Coronary Artery Disease; Creatinine; Cyclosporine; Cystic Fibrosis; Emphysema; Female; Glomerular Filtration Rate; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Lung Transplantation; Male; Middle Aged; Monitoring, Physiologic; Pulmonary Disease, Chronic Obstructive | 2009 |
Cardiac allograft vasculopathy compared by intravascular ultrasound sonography: everolimus to mycophenolate mofetil--one single-center experience.
Topics: Adult; Aged; Coronary Artery Disease; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Heart Transplantation; Humans; Immunosuppressive Agents; Linear Models; Male; Middle Aged; Multivariate Analysis; Mycophenolic Acid; Predictive Value of Tests; Risk Assessment; Risk Factors; Sirolimus; Steroids; Taiwan; Time Factors; Treatment Outcome; Ultrasonography, Interventional | 2012 |
Two good reasons for an angiotensin-II type 1 receptor blockade with losartan after cardiac transplantation: reduction of incidence and severity of transplant vasculopathy.
Topics: Acute Disease; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Coronary Artery Disease; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Incidence; Losartan; Models, Animal; Postoperative Complications; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Severity of Illness Index | 2003 |
Longer-term risks associated with 10-year survival after heart transplantation in the cyclosporine era.
Topics: Adult; Age Factors; Case-Control Studies; Coronary Artery Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Heart Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Lymphoproliferative Disorders; Male; Multivariate Analysis; Obesity; Postoperative Complications; Risk Factors; Sex Factors; Time Factors | 2003 |
Analysis of survivors more than 10 years after heart transplantation in the cyclosporine era: Stanford experience.
Topics: Adult; Cohort Studies; Coronary Artery Disease; Cyclosporine; Diabetes Mellitus; Female; Graft Rejection; Heart Transplantation; Humans; Hyperlipidemias; Hypertension; Immunosuppressive Agents; Incidence; Male; Neoplasms; Registries; Renal Insufficiency; Survival Analysis; Survival Rate; Time Factors | 2004 |
Inhibition of graft coronary arteriosclerosis after heart transplantation.
Topics: Animals; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Dose-Response Relationship, Drug; Graft Occlusion, Vascular; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Models, Animal; Rats; Rats, Inbred ACI; Rats, Inbred Lew; Tunica Intima; Tunica Media | 2004 |
Cyclosporine treatment of high dose and long duration reduces the severity of graft coronary artery disease in rodent cardiac allografts.
Topics: Animals; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Ectodysplasins; Follow-Up Studies; Genes, MHC Class II; Graft vs Host Reaction; Heart Transplantation; Immunohistochemistry; Immunosuppressive Agents; Macrophages; Male; Membrane Proteins; Rats; Rats, Inbred ACI; Transplantation, Homologous; Treatment Outcome; Tunica Intima | 2005 |
Cyclosporine mitigates graft coronary artery disease in murine cardiac allografts: description and validation of a novel fully allogeneic model.
Topics: Animals; Chromatography, Liquid; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Follow-Up Studies; Gas Chromatography-Mass Spectrometry; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Male; Mice; Mice, Inbred C57BL; Monocytes; Myocytes, Cardiac; Transplantation, Homologous; Treatment Outcome | 2005 |
Ten- and 20-year survivors of pediatric orthotopic heart transplantation.
Topics: Actuarial Analysis; Adolescent; Bacterial Infections; Cardiomyopathies; Child; Child, Preschool; Coronary Artery Disease; Cyclosporine; Female; Graft Rejection; Heart Defects, Congenital; Heart Transplantation; Humans; Immunosuppressive Agents; Infant; Lymphoproliferative Disorders; Male; Reoperation; Retrospective Studies; Survival Analysis; Survivors; Tacrolimus | 2006 |
Early proliferation of medial smooth muscle cells in coronary arteries of rabbit cardiac allografts during immunosuppression with cyclosporine A.
Topics: Animals; Cell Division; Coronary Artery Disease; Cyclosporine; Graft Occlusion, Vascular; Graft Rejection; Heart Transplantation; Muscle, Smooth, Vascular; Rabbits; Time Factors | 1995 |
[An experimental study of coronary arteriosclerosis after heart transplantation].
Topics: Animals; Coronary Artery Disease; Cyclosporine; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Lipids; Male; Rats; Rats, Inbred F344; Rats, Inbred Lew | 1993 |
[Effects of acute rejection on the endothelium-dependent relaxation of coronary arteries of the transplanted heart in dogs].
Topics: Acute Disease; Animals; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Dogs; Endothelium, Vascular; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Transplantation, Heterotopic; Vasodilation | 1995 |
No coronary atherosclerotic changes were found after heart transplantation in tolerance-induced rats.
Topics: Animals; Blood Transfusion; Coronary Artery Disease; Cyclosporine; Heart Transplantation; Immune Tolerance; Immunosuppression Therapy; Immunosuppressive Agents; Male; Postoperative Complications; Rats; Rats, Inbred F344; Rats, Inbred Lew; Rats, Inbred Strains; Transplantation, Homologous; Transplantation, Isogeneic | 1996 |
Cyclosporine a inhibits tissue factor expression in monocytes/macrophages.
Topics: Biological Transport; Blood Coagulation Factors; Cell Nucleus; Cells, Cultured; Coronary Artery Disease; Cyclosporine; Depression, Chemical; Gene Expression Regulation; Heart Transplantation; Humans; Lipopolysaccharides; Macrophages; Monocytes; NF-kappa B; Postoperative Complications; Protein Binding; Thromboplastin; Transcription, Genetic | 1996 |
L-arginine prevents heart transplant arteriosclerosis by modulating the vascular cell proliferative response to insulin-like growth factor-I and interleukin-6.
Topics: Animals; Antineoplastic Agents; Aorta; Arginine; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Graft Rejection; Heart Transplantation; Histocompatibility Antigens Class II; Hyperplasia; Immunosuppressive Agents; Insulin-Like Growth Factor I; Interleukin-6; Macrophages; Male; Nitric Oxide; Postoperative Complications; Rabbits; T-Lymphocytes; Transplantation, Homologous | 1996 |
Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolition of MHC class II antigen expression.
Topics: Animals; Coronary Artery Disease; Cyclosporine; Estradiol; Graft Rejection; Heart Transplantation; Histocompatibility Antigens Class II; Immunohistochemistry; Immunosuppressive Agents; Macrophages; Male; Postoperative Complications; Rabbits; T-Lymphocytes; Transplantation, Homologous; Tunica Intima | 1996 |
Adhesion molecule P-selectin and vascular cell adhesion molecule-1 in enhanced heart allograft arteriosclerosis in the rat.
Topics: Acute Disease; Animals; Chronic Disease; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Endothelium, Vascular; Graft Rejection; Heart Transplantation; Linear Models; P-Selectin; Rats; Rats, Inbred Strains; Rats, Inbred WF; Vascular Cell Adhesion Molecule-1 | 1997 |
Role of hypercholesterolemia in accelerated transplant coronary vasculopathy: results of surgical therapy with partial ileal bypass in rabbits undergoing heterotopic heart transplantation.
Topics: Animals; Cholesterol; Cholesterol, Dietary; Coronary Artery Disease; Coronary Disease; Coronary Vessels; Cyclosporine; Disease Models, Animal; Heart Transplantation; Hypercholesterolemia; Immunosuppressive Agents; Male; Postoperative Complications; Rabbits; Risk Factors | 1997 |
Inducible nitric oxide synthase expression in coronary arteries of transplanted human hearts with accelerated graft arteriosclerosis.
Topics: Adolescent; Adult; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Enzyme Induction; Heart Transplantation; Humans; Immunohistochemistry; Immunosuppressive Agents; In Situ Hybridization; Macrophages; Middle Aged; Myocardium; Nitric Oxide Synthase; RNA, Messenger | 1997 |
Vascular effects of cyclosporin A and acute rejection in canine heart transplantation.
Topics: Acetylcholine; Acute Disease; Adenosine Diphosphate; Animals; Coronary Artery Disease; Coronary Circulation; Coronary Vessels; Cyclosporine; Dinoprost; Dogs; Dose-Response Relationship, Drug; Endothelium, Vascular; Factor VIII; Graft Rejection; Heart Transplantation; Immunoenzyme Techniques; Immunoglobulin G; Immunoglobulin M; Immunosuppressive Agents; In Vitro Techniques; Muscle, Smooth, Vascular; Myocardium; Nitroprusside; Serotonin; Thrombin; Transplantation, Heterotopic; Tunica Intima; Vasoconstriction; Vasodilation | 1997 |
Effect of low molecular weight heparin on suppression of chronic graft vascular disease in a rat cardiac allograft model.
Topics: Anastomosis, Surgical; Animals; Aorta, Abdominal; Chronic Disease; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Fibrinolytic Agents; Heart Transplantation; Heparin, Low-Molecular-Weight; Immunosuppressive Agents; Male; NG-Nitroarginine Methyl Ester; Postoperative Complications; Rats; Rats, Inbred ACI; Rats, Inbred Strains; Transplantation, Heterotopic; Transplantation, Homologous; Vena Cava, Inferior | 1998 |
Effect of cyclosporine on chronic graft vascular disease in a rat cardiac isograft model.
Topics: Animals; Coronary Artery Disease; Cyclosporine; Fibrinolytic Agents; Heart Transplantation; Heparin, Low-Molecular-Weight; Immunosuppressive Agents; Male; Nitrates; Nitrites; Postoperative Complications; Rats; Rats, Inbred ACI; Transplantation, Heterotopic; Transplantation, Isogeneic | 1998 |
Inhibitory effect of Multiglycosidorum tripterygii on coronary arteriosclerosis after heart transplantation.
Topics: Animals; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Drugs, Chinese Herbal; Heart Transplantation; Immunosuppressive Agents; Myocardium; Platelet-Derived Growth Factor; Postoperative Complications; Rats; Rats, Inbred Lew; Rats, Wistar; RNA, Messenger; Tripterygium | 1998 |
Implication of HLA mismatch in the clinical outcome of orthotopic heart transplantation.
Topics: Adolescent; Adult; Antilymphocyte Serum; Azathioprine; Child; Coronary Artery Disease; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Heart Function Tests; Heart Transplantation; Histocompatibility Testing; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Postoperative Complications; Prednisone; Retrospective Studies; Treatment Outcome | 1998 |
Coronary arteriosclerosis did not occur in the transplanted hearts of tolerance-induced rats: analysis from platelet-derived growth factor expression.
Topics: Animals; Blood Transfusion; Coronary Artery Disease; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppression Therapy; Male; Platelet-Derived Growth Factor; Rats; Rats, Inbred F344; Rats, Inbred Lew; Rats, Inbred Strains; Time Factors; Transplantation, Homologous; Transplantation, Isogeneic | 1998 |
The detection of chronic heart graft rejection by 31P NMR spectroscopy.
Topics: Adenosine Triphosphate; Animals; Chronic Disease; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Magnetic Resonance Spectroscopy; Myocardium; Phosphocreatine; Phosphorus; Phosphorus Isotopes; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Homologous | 1999 |
Multiglycosidorum tripterygii, a new immunosuppressant, supresses coronary arteriosclerosis after heart transplantation.
Topics: Animals; Blotting, Northern; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Male; Platelet-Derived Growth Factor; Polymerase Chain Reaction; Rats; Rats, Inbred Lew; Rats, Wistar; RNA; Transplantation, Homologous | 1999 |
Relation between long-term steroid treatment after heart transplantation, hypofibrinolysis and myocardial microthrombi generation.
Topics: Azathioprine; Biopsy; Coronary Artery Disease; Cyclosporine; Drug Therapy, Combination; Female; Fibrinolysis; Glucocorticoids; Heart Diseases; Heart Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Myocardium; Postoperative Care; Prednisone; Thrombosis; Time Factors | 1999 |
Late multiglycosidorum tripterygium treatment ameliorates established graft coronary arteriosclerosis after heart transplantation in the rat.
Topics: Animals; Coronary Artery Disease; Cyclosporine; Drugs, Chinese Herbal; Graft Rejection; Heart Transplantation; Immunosuppressive Agents; Male; Postoperative Complications; Rats; Rats, Inbred Lew; Rats, Inbred WKY | 1999 |
Effects of immunosuppressants on platelet-derived growth factor-A chain mRNA expression and coronary arteriosclerosis in rat cardiac allografts.
Topics: Animals; Coronary Artery Disease; Cyclosporine; Drugs, Chinese Herbal; Graft Rejection; Guanidines; Heart Transplantation; Immunosuppressive Agents; Male; Myocardium; Platelet-Derived Growth Factor; Rats; Rats, Wistar; RNA, Messenger; Transplantation, Homologous; Tripterygium | 1999 |
FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation.
Topics: Animals; Coronary Artery Disease; Cyclosporine; Disease Progression; Fingolimod Hydrochloride; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Postoperative Complications; Propylene Glycols; Sphingosine; T-Lymphocytes, Cytotoxic | 1999 |
Inhibitory effect of triptolide on platelet derived growth factor-A and coronary arteriosclerosis after heart transplantation.
Topics: Animals; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Diterpenes; Epoxy Compounds; Gene Expression Regulation; Heart Transplantation; Immunosuppressive Agents; Male; Phenanthrenes; Platelet-Derived Growth Factor; Postoperative Complications; Rats; Rats, Inbred Lew; Rats, Inbred Strains; Transplantation, Homologous | 1999 |
Intravascular ultrasound for assessment of coronary allograft vasculopathy.
Topics: Clinical Trials as Topic; Coronary Angiography; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Follow-Up Studies; Heart Transplantation; Humans; Immunosuppressive Agents; Multicenter Studies as Topic; Practice Guidelines as Topic; Prognosis; Prospective Studies; Research; Risk Factors; Tacrolimus; Time Factors; Ultrasonography, Interventional | 2000 |
Cyclosporine does not enhance the development of accelerated coronary artery disease: experimental study in a rat cardiac transplant model.
Topics: Animals; Cell Survival; Coronary Artery Disease; Coronary Restenosis; Cyclosporine; Disease Models, Animal; Dose-Response Relationship, Drug; Graft Rejection; Graft Survival; Heart Rate; Heart Transplantation; Immunosuppressive Agents; Male; Models, Cardiovascular; Random Allocation; Rats; Rats, Inbred F344; Rats, Inbred Lew; Time Factors; Treatment Outcome; Weight Gain; Withholding Treatment | 2002 |
Paclitaxel and cyclosporine A show supra-additive antiproliferative effects on smooth muscle cells by activation of protein kinase C.
Topics: Angiogenesis Inhibitors; Animals; Apoptosis; Cattle; Cell Division; Cells, Cultured; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Cyclosporine; Enzyme Activation; Immunosuppressive Agents; Muscle, Smooth, Vascular; Paclitaxel; Protein Kinase C | 2002 |
[Organ transplantation].
Topics: Adult; Aged; Animals; Brain Death; Catheterization, Swan-Ganz; Coronary Artery Disease; Cyclosporine; Denervation; Dogs; Female; Heart; Heart Transplantation; Herpesviridae Infections; Humans; Immunosuppression Therapy; Lung; Lung Transplantation; Male; Middle Aged; Myocardial Infarction; Organ Transplantation; Postoperative Complications; Rats; Tissue Survival | 1992 |
Immunologically induced coronary artery stenosis in allografts after heart and heart-lung transplantation in rats.
Topics: Animals; Coronary Artery Disease; Coronary Vessels; Cyclosporine; Graft Rejection; Graft Survival; Heart Transplantation; Heart-Lung Transplantation; Male; Rats; Rats, Inbred F344 | 1992 |
Investigation of heart transplant coronary atherosclerosis.
Topics: Coronary Artery Disease; Coronary Vessels; Cyclosporine; Heart Transplantation; Humans; Immunosuppression Therapy; Risk Factors; Ultrasonography | 1992 |